POA Pharma is now a Galen company

Galen, the privately owned global pharmaceutical sales and marketing company, is delighted to announce the acquisition and takeover of boutique healthcare company, POA Pharma.

New website coming soon

  • POA Pharma Scandinavia and Desma Healthcare have signed a Licensing agreement for the Nordic Region

    About Akineton. Biperiden is a medium-parkinsonian of anticholinergic type. In the Nordics, the medicine exists under the name of Akineton. Today Akineton is mainly used to prevent extrapyramidal side effects of typical anti-psychotics. Akineton is currently marketed in more than 40 countries and is since 2007 on the WHO´s list of Essential Drugs.

    About Desma Healthcare.  Desma Healthcare is an Italian pharmaceutical group with a long tradition, being present on Italian market through its affiliate “Laboratorio Farmaceutico SIT” since 1927. It is an entrepreneurial reality in constant development, with a turnover of more than 80 million euro, in Italy and in 40 international markets, such as Europe, Middle and Far East and Latin America. Main therapeutic areas in which Desma Healthcare operates with prescription and OTC products, biocides and Foods Supplements are Cardiology, Disinfection, Gastroenterology, Neurology and Venous Insufficiency.Desma Healthcare is the reliable partner committed to create a collaboration network with pharmacies, authorities, distributors, patients and customers



    About POA Pharma Scandinavia. POA is a young Boutique Health care company, 4 years old, with offices in the four Nordic countries and in US. POA stands for Point Of Action, new ideas and new combinations and is occupied within three strategic areas:

    1. The Nordics were POA represent 14 Pharmaceutical producers from 11 countries. The products are placed in 9 areas of Competence – therapy sections.

    2. Central marketing and development of own products.

    3. Export with distribution agreement with close to 40 countries.

    Leave a reply →